Multisystem organ failure after large volume injection of castor oil

Annals of Plastic Surgery

Volumn 62, Issue 1, 2009, Pages 12-14

  Smith, Silas W ^a,b   Graber, Nathan M ^c   Johnson, Rudolph C ^d   Barr, John R ^d   Hoffman, Robert S ^a,b   Nelson, Lewis S ^a,b  

^a NEW YORK CITY POISON CONTROL CENTER   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Castor oil; Injection; Multisystem organ failure; Ricinine; Transgendered

Indexed keywords

BIOLOGICAL MARKER; CASTOR OIL; CILASTATIN PLUS IMIPENEM; SODIUM CHLORIDE; VANCOMYCIN;

ABDOMINAL PAIN; ADULT; ARTICLE; ARTIFICIAL VENTILATION; BLOOD SAMPLING; BUTTOCK; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; EMERGENCY WARD; ERYTHEMA; FEVER; HEADACHE; HEMATURIA; HEMODIALYSIS; HEMOLYSIS; HEPATITIS; HIP; HUMAN; INJECTION SITE INFECTION; INTENSIVE CARE; JAUNDICE; KIDNEY FAILURE; LABORATORY TEST; MALE; MALE TO FEMALE TRANSSEXUAL; MULTIPLE ORGAN FAILURE; PAIN; PRIORITY JOURNAL; RESPIRATORY DISTRESS; RICINUS COMMUNIS; TACHYCARDIA; THORAX PAIN; THROMBOCYTOPENIA; TINNITUS; URINALYSIS; VOMITING;

ADULT; CASTOR OIL; COSMETIC TECHNIQUES; HUMANS; INJECTIONS; MALE; MULTIPLE ORGAN FAILURE; TRANSSEXUALISM;

EID: 65949089835     PISSN: 01487043     EISSN: None     Source Type: Journal    
DOI: 10.1097/SAP.0b013e31817763bd     Document Type: Article

References (35)

1. The American Society for Aesthetic Plastic Surgery (ASAPS). Cosmetic Surgery National Data Bank Statistics [online]. New York, NY: ASAPS Communications Office; 2007. Available at: http://www.surgery.org/download/ 2007stats.pdf Accessed March 21, 2008.
2. Kenagy GP. Transgender health: findings from two needs assessment studies in Philadelphia. Health Soc Work. 2005;30:19-26.
3. Hage JJ, Kanhai RC, Oen AL, et al. The devastating outcome of massive subcutaneous injection of highly viscous fluids in male-to-female transsexuals. Plast Reconstr Surg. 2001;107:734-741.
4. Hexsel DM, Hexsel CL, Iyengar V. Liquid injectable silicone: history, mechanism of action, indications, technique, and complications. Semin Cutan Med Surg. 2003;22:107-114.
5. Klein AW. Soft tissue augmentation 2006: filler fantasy. Dermatol Ther. 2006;19:129-133.
6. Darby SM, Miller ML, Allen RO. Forensic determination of ricin and the alkaloid marker ricinine from castor bean extracts. J Forensic Sci. 2001;46:1033-1042.
7. Johnson RC, Lemire SW, Woolfitt AR, et al. Quantification of ricinine in rat and human urine: a biomarker for ricin exposure. J Anal Toxicol. 2005;29:149-155.
8. Thomas JD, Johnson RC, Anderson IB, et al. Intentional castor bean ingestion with serial ricinine levels. Clin Toxicol. 2006;44:734-735 [abstract].
9. Katz KA, Furnish TJ. Dermatology-related epidemiologic and clinical concerns of men who have sex with men, women who have sex with women, and transgender individuals. Arch Dermatol. 2005;141:1303-1310.
10. Duffy DM. Silicone: a critical review. Adv Dermatol. 1990;5:93-107.
11. Rollins CE. Disseminated lipogranulomas and sudden death from self-administered mineral oil. Am JForens Med Pathol. 1997;18:100-103.
12. Bhagat R, Holmes IH, Kulaga A, et al. Self-injection with olive oil: a cause of lipoid pneumonia. Chest. 1995;107:875-876.
13. Allevato MA, Pastorale EP, Zamboni M, et al. Complications following industrial liquid silicone injection. Int J Dermatol. 1996;35:193-195.
14. Behar TA, Anderson EE, Barwick WJ, et al. Sclerosing lipogranulomatosis: a case report of scrotal injection of automobile transmission fluid and literature review of subcutaneous injection of oils. Plast Reconstr Surg. 1993;91:352-361.
15. Wang J, Shih TTF, Chang KJ, et al. Silicone migration from silicone-injected breasts: magnetic resonance images. Ann Plast Surg. 2002;48:617-621.
16. Burdock GA, Carabin IG, Griffiths JC. Toxicology and pharmacology of sodium ricinoleate. Food Chem Toxicol. 2006;44:1689-1698.
17. Larsen SW, Rinvar E, Svendsen O, et al. Determination of the disappearance rate of iodine-125 labelled oils from the injection site after intramuscular and subcutaneous administration to pigs. Int J Pharm. 2001;230:67-75.
18. Gaginella TS, Haddad AC, Go VL, et al. Cytotoxicity of ricinoleic acid (castor oil) and other intestinal secretagogues on isolated intestinal epithelial cells. J Pharmacol Exp Ther. 1977;201:259-266.
19. Fox DA, Epstein ML, Bass P. Surfactants selectively ablate enteric neurons of the rat jejunum. J Pharmacol Exp Ther. 1983;227:538-544.
20. Roman ID, Monte MJ, Esteller A, et al. Cholestasis in the rat by means of intravenous administration of cyclosporine vehicle, cremophor EL. Transplantation. 1989;48:554-548.
21. Besarab A, Jarrell BE, Hirsch S, et al. Use of the isolated perfused kidney model to assess the acute pharmacologic effects of cyclosporine and its vehicle, cremophor EL. Transplantation. 1987;44:195-201.
22. Gullikson GW, Bass P. Comparative effects of various surfactants on the small intestine and erythrocyte membranes, in vitro. Fed Proc. 1976;35:463.
23. Cury-Boaventura MF, Gorjao R, de Lima TM, et al. Comparative toxicity of oleic and linoleic acid on human lymphocytes. Life Sci. 2006;78:1448-1456.
24. Lorenz W, Schmal A, Schult H, et al. Histamine release and hypotensive reactions in dogs by solubilizing agents and fatty acids: analysis of various components in cremophor El and development of a compound with reduced toxicity. Agents Actions. 1982;12:64-80.
25. Gaudy JH, Sicard JF, Lhoste F, et al. The effects of cremophor EL in the anaesthetized dog. Can J Anaesth. 1987;34:122-129.
26. Savege TM, Foley EI, Simpson BR. Some cardiorespiratory effects of cremophor el in man. Br J Anaesth. 1973;45:515-517.
27. Szebeni J. Complement activation-related pseudoallergy: a new class of drug-induced acute immune toxicity. Toxicology. 2005;216:106-121.
28. ten Tije AJ, Verweij J, Loos WJ, et al. Pharmacological effects of formulation vehicles: implications for cancer chemotherapy. Clin Pharmacokinet. 2003; 42:665-685.
29. Behrends M, Beiderlinden M, Peters J. Acute lung injury after peppermint oil injection. Anesth Analg. 2005;101:1160-1162.
30. Rylander C, Hogman M, Perchiazzi G, et al. Oleic acid lung injury: a morphometric analysis using computed tomography. Acta Anaesthesiol Scand. 2004;48:1123-1129.
31. Clouse ME, Hallgrimsson J, Wenlund DE. Complications following lymphography with particular reference to pulmonary oil embolization. Am J Roentgenol Radium Ther Nucl Med. 1966;96:972-978.
32. Chastre J, Brun P, Soler P, et al. Acute and latent pneumonitis after subcutaneous injections of silicone in transsexual men. Am Rev Respir Dis. 1987;135:236-240.
33. Ferraz AC, Pereira LF, Ribeiro RL, et al. Ricinine-elicited seizures. A novel chemical model of convulsive seizures. Pharmacol Biochem Behav. 2000;65: 577-583.
34. Ferraz AC, Angelucci ME, Da Costa ML, et al. Pharmacological evaluation of ricinine, a central nervous system stimulant isolated from Ricinus commu-nis. Pharmacol Biochem Behav. 1999;63:367-375.
35. Zhan J, Zhou P. A simplified method to evaluate the acute toxicity of ricin and ricinus agglutinin. Toxicology. 2003;186:119-123.